Target organ | μGy/MBq | mrad/mCi |
---|---|---|
Adrenals | 3.5 | 13.0 |
Brain | 6.9 | 25.6 |
Breasts | 1.7 | 6.2 |
Gallbladder wall | 32.4 | 120.0 |
Lower large intestine wall | 2.0 | 7.3 |
Small intestine | 7.5 | 27.8 |
Stomach | 2.3 | 8.6 |
Upper large intestine wall | 3.0 | 11.0 |
Heart wall | 6.6 | 24.4 |
Kidneys | 16.6 | 61.4 |
Liver | 22.2 | 82.1 |
Lungs | 16.9 | 62.6 |
Muscle | 1.8 | 6.5 |
Ovaries | 2.2 | 8.2 |
Pancreas | 3.4 | 12.6 |
Red marrow | 1.9 | 6.9 |
Bone surfaces | 2.2 | 8.3 |
Skin | 1.3 | 4.6 |
Spleen | 9.4 | 35.0 |
Testes | 1.3 | 4.9 |
Thymus | 1.9 | 7.1 |
Thyroid | 1.5 | 5.4 |
Urinary bladder wall | 15.7 | 58.1 |
Uterus | 2.5 | 9.3 |
Total body | 2.8 | 10.3 |
Dynamic urinary bladder model was used, based on 2.4-h void. Effective dose equivalent = 9.2 μSv/MBq (33.9 mrem/mCi). Effective dose = 5.7 μSv/MBq (21.1 mrem/mCi).